Endovascular Procedures With Computer Assistance in the Chronic Occlusive Arthritis of the Lower Limbs on the Femoro-popliteal Stage. (PANORAMIC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03669978 |
|
Recruitment Status :
Completed
First Posted : September 13, 2018
Last Update Posted : September 13, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Peripheral Arterial Disease | Procedure: Creation of a bone and arterial panorama using EndoNaut® software. |
| Study Type : | Observational |
| Actual Enrollment : | 60 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Endovascular Procedures With Computer Assistance in the Chronic Occlusive Arthritis of the Lower Limbs on the Femoro-popliteal Stage. |
| Actual Study Start Date : | August 8, 2017 |
| Actual Primary Completion Date : | December 12, 2017 |
| Actual Study Completion Date : | December 12, 2017 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Patients with chronic occlusive arthritis of the Lower Limbs
Patients with chronic occlusive arthritis of the Lower Limbs with lesions on the femoro-popliteal stage and candidates for endovascular treatment of these lesions. Creation of a bone and arterial panorama using EndoNaut® software. |
Procedure: Creation of a bone and arterial panorama using EndoNaut® software.
The routine care procedure begins with staged injections of contrast medium to provide a map of the lesions. The lesions are then treated by angioplasty with or without stenting. New injections of contrast product are made to control the results of the treatment. As part of this pilot study, the assistive software and its interface will be linked and with the mobile C-arm X-ray system. Scopic images and angiograms will be retransmitted to be processed by the EndoNaut® software. Other Name: EndoNaut® software. |
- Quantification of the registration errors [ Time Frame: At the inclusion day ]The 2D-2D registration is driven by an error index (intrinsic software criterion) given by the software at the end of the registration process
- Volume of contrast product used during the routine care procedure (ml) [ Time Frame: At the inclusion day ]Volume are reported in mL
- Irradiation parameters: evaluation of the Fluoroscopy duration (min) [ Time Frame: At the inclusion day ]Parameter given by the X-ray imaging device
- Irradiation parameters: dose-area quantification (mGy/m2) [ Time Frame: At inclusion ]Parameter given by the X-ray imaging device
- Irradiation parameters: measurement of air Kerma (mGy) [ Time Frame: At the inclusion day ]Parameter given by the X-ray imaging device
- Irradiation parameters: evaluation of the number of required angiograms [ Time Frame: At the inclusion day ]Parameter given by the X-ray imaging device
- Operating time (min) [ Time Frame: At the inclusion day ]Delay between the beginning (patient anesthesia) and the end (patient transferred to post interventional care room) of the procedure
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients with peripheral arterial disease of the lower limbs, all clinical stages, lesions of the femoro-popliteal stage and candidates for endovascular treatment of these lesions.
- Major patients
- Patients not opposed to their participation in the study
Exclusion Criteria:
- Patients requiring conventional surgical revascularization.
- Patient under legal protection (guardianship, safeguard of justice).
- Pregnant or lactating women
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03669978
| France | |
| Rennes Univesity Hospital | |
| Rennes, France, 35000 | |
| Principal Investigator: | Adrien Kaladji, MD | Rennes University Hospital |
| Responsible Party: | Rennes University Hospital |
| ClinicalTrials.gov Identifier: | NCT03669978 |
| Other Study ID Numbers: |
35RC17_3070 |
| First Posted: | September 13, 2018 Key Record Dates |
| Last Update Posted: | September 13, 2018 |
| Last Verified: | September 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Occlusive arthritis bone panorama arterial panorama |
|
Arthritis Peripheral Arterial Disease Peripheral Vascular Diseases Joint Diseases Musculoskeletal Diseases |
Atherosclerosis Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Cardiovascular Diseases |

